Semi-annual Report for 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Semi-annual Report for 2026
Filed with SSE ·
6ix hasn’t read this filing yet.
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Resignation of Independent Director
- Announcement on Implementation of Cancellation of Repurchased Shares and Share Changes
- Announcement on Imposition of Other Risk Warnings and Trading Suspension
- Announcement on Notifying Creditors Regarding the Cancellation of Repurchased Shares
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from CABIO Biotech (Wuhan)
- Announcement on Progress of the Imposition of Other Risk Warning on the Company's Shares
- Announcement on Receipt of the Notice of Response to Retrial and Progress of Litigation
- (688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Resignation of the Securities Affairs Representative
- (688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Provision for Credit and Asset Impairment for the First Three Quarters of 2026
- (688089)"Cabio Biotech (Wuhan) Co., Ltd."Report for Q3 2026
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)